Atea Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Atea Pharmaceuticals, Inc.
CIK #0001593899
EDGAR Form CIK 2011 - 2025
10-K [0001593899]
10-Q [0001593899]
3 [0001593899]
4 [0001593899]
8-K [0001593899]
D [0001593899]
SC 13D [0001593899]
SC 13G [0001593899]
Form 13D/13G Filer Form 13D/13G Subject Filed
Radoff Bradley Louis Atea Pharmaceuticals Inc [2025-03-04]
BML Investment Partners LP Atea Pharmaceuticals Inc [2024-12-16]
BML Investment Partners LP Atea Pharmaceuticals Inc [2024-02-07]
BML Investment Partners LP Atea Pharmaceuticals Inc [2023-10-02]
Tang Capital Partners LP Atea Pharmaceuticals Inc [2023-05-22]
Vanguard Group Inc Atea Pharmaceuticals Inc [2022-02-09]
BlackRock Inc Atea Pharmaceuticals Inc [2022-02-04]
EcoR1 Capital LLC Atea Pharmaceuticals Inc [2021-12-10]
RA Capital Management LP Atea Pharmaceuticals Inc [2021-02-16]
Morningside Venture Investments Ltd Atea Pharmaceuticals Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2025
Berman Howard
Atea Pharmaceuticals, Inc.
Murphy Polly A.
Berger Franklin M
Duncan Barbara Gayle
Polsky Bruce
Adams Jerome M.
Lucidi Bruno
Kirsch Arthur S
Foster Wayne
View All
Terms | Privacy | Guide
tony@aum13f.com